"Head and Neck Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
Descriptor ID |
D006258
|
MeSH Number(s) |
C04.588.443
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Head and Neck Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Head and Neck Neoplasms".
This graph shows the total number of publications written about "Head and Neck Neoplasms" by people in this website by year, and whether "Head and Neck Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
1998 | 3 | 0 | 3 |
1999 | 1 | 0 | 1 |
2002 | 3 | 3 | 6 |
2003 | 6 | 0 | 6 |
2004 | 4 | 0 | 4 |
2005 | 2 | 0 | 2 |
2006 | 3 | 2 | 5 |
2007 | 2 | 0 | 2 |
2008 | 3 | 0 | 3 |
2009 | 2 | 0 | 2 |
2010 | 9 | 1 | 10 |
2011 | 4 | 0 | 4 |
2012 | 2 | 0 | 2 |
2013 | 2 | 0 | 2 |
2014 | 5 | 0 | 5 |
2015 | 3 | 0 | 3 |
2016 | 3 | 0 | 3 |
2017 | 4 | 1 | 5 |
2018 | 3 | 0 | 3 |
2019 | 2 | 0 | 2 |
2020 | 3 | 1 | 4 |
2021 | 4 | 0 | 4 |
2022 | 7 | 0 | 7 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Head and Neck Neoplasms" by people in Profiles.
-
Exposure to Secondhand Smoke Extract Increases Cisplatin Resistance in Head and Neck Cancer Cells. Int J Mol Sci. 2024 Jan 14; 25(2).
-
MiR-205-5P AS POTENTIAL BIOMARKER AND THERAPEUTIC TARGET IN HEAD AND NECK SQUAMOUS CELL CARCINOMA. Exp Oncol. 2022 12; 44(4):337-338.
-
18 F-fludeoxyglucose positron emission computed tomography (18 F-FDG-PET/CT) versus 68 Ga-DOTATATE-PET/CT in patients with head and neck cancer: Comparisons and implications for treatment. Head Neck. 2023 02; 45(2):347-354.
-
MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR?ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS. Exp Oncol. 2022 11; 44(3):263-264.
-
A Comparison of the Characteristics of Cytokine Storm between Lichen Planus and Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev. 2022 Nov 01; 23(11):3843-3849.
-
Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival. Oral Oncol. 2022 11; 134:106072.
-
Neoadjuvant QUAD shot for downstaging or temporizing locally advanced oral cavity cancer prior to definitive surgery. Oral Oncol. 2022 10; 133:106029.
-
Targeting cancer associated fibroblasts - A TGF-ß based immunotherapy for head and neck squamous cell carcinoma. Oral Oncol. 2022 07; 130:105899.
-
Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer. BMC Cancer. 2022 Apr 09; 22(1):383.
-
Analysis of Systematic Reviews in Clinical Practice Guidelines for Head and Neck Cancer. Laryngoscope. 2022 10; 132(10):1976-1983.